Ben Derman, MD

About

Ben Derman, MD, specializes in hematology and oncology. Dr. Derman is an expert in multiple myeloma and other plasma cell disorders, such as monoclonal gammopathy, amyloidosis, plasmacytoma, and POEMS syndrome. He also diagnoses and treats cancerous conditions and uses the most innovative techniques, including CAR T-cell therapy and stem cell transplantation to deliver long-term success for his patients.

Along with his clinical practice, Dr. Derman remains committed to research. Currently, he is focused on identifying strategies that can lead to a possible cure for multiple myeloma, including using very sensitive tests that measure small amounts of residual cancer cells in the body called ‘minimal residual disease’ (MRD) to guide decision making.

Dr. Derman is also investigating new methods and therapies designed to improve outcomes and quality of life for his patients. Additionally, he is interested in evaluating reasons for racial disparities in multiple myeloma outcomes to better understand and care for those patients. His work has been published in several peer-reviewed journals, including the Journal of Immunotherapy of Cancer, Blood, Blood Advances, Blood Cancer Journal, Leukemia and Lymphoma and British Journal of Haematology.

Assistant Professor of Medicine

Clinical Expertise

About

Location

Thanks to our HealthTree Community for Myeloma Sponsors:

Follow Us

Apps & Programs

News

Events

Round Tables

Podcast

Chapters

Research

Patient Resources

Black & Hispanic Support

HealthTree Info

Need Help?

Legal Info

Clinical Expertise

About

Location

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Thanks to our HealthTree Community for Myeloma Sponsors:

Follow Us

Apps & Programs

News

Events

Round Tables

Podcast

Chapters

Research

Patient Resources

Black & Hispanic Support

HealthTree Info

Need Help?

Legal Info